Chat with us
Research Assistance
Online
  • Please enter your first name.

Argentina Immunosuppressant Drugs Market, 2020-2027

The immunosuppressant drugs market in Argentina is expected to reach a projected revenue of US$ 808.4 million by 2027. A compound annual growth rate of 7.9% is expected of Argentina immunosuppressant drugs market from 2021 to 2027.

  • Pharmaceuticals
    • Metabolic Disorders Treatment
      • Immunosuppressant Drugs Market
Revenue, 2020 (US$M)
$475.1
Forecast, 2027 (US$M)
$808.4
CAGR, 2021 - 2027
7.9%
Report Coverage
Argentina

Argentina Immunosuppressant Drugs Market, 2016-2027 (US$M)

Argentina Immunosuppressant Drugs Market, 2016-2027 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the immunosuppressant drugs market

Every figure cited from GVR research

Argentina immunosuppressant drugs market highlights

  • The Argentina immunosuppressant drugs market generated a revenue of USD 475.1 million in 2020 and is expected to reach USD 808.4 million by 2027.
  • The Argentina market is expected to grow at a CAGR of 7.9% from 2021 to 2027.
  • In terms of segment, monoclonal antibodies was the largest revenue generating drug class in 2020.
  • Monoclonal Antibodies is the most lucrative drug class segment registering the fastest growth during the forecast period.


Immunosuppressant drugs market data book summary

Market revenue in 2020USD 475.1 million
Market revenue in 2027USD 808.4 million
Growth rate7.9% (CAGR from 2020 to 2027)
Largest segmentMonoclonal antibodies
Fastest growing segmentMonoclonal Antibodies
Historical data2016 - 2019
Base year2020
Forecast period2021 - 2027
Quantitative unitsRevenue in USD million
Market segmentationCalcineurin Inhibitors, MTOR Inhibitors, Antiproliferative Agents, Monoclonal Antibodies


Other key industry trends

  • In terms of revenue, Argentina accounted for 0.5% of the global immunosuppressant drugs market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
  • In Latin America, Brazil immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2027.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 1,965.9 million by 2027.

Argentina is deemed to be one of the emerging markets worldwide but the country still struggles to maintain credibility with the investors and the inflation rates in the country have been very high.

Argentina’s health sector has gone through major transformations in the years with a reduction of state involvement in social services in favor of privatization and decentralization of healthcare. Dental caries and gingival affections are major oral health risks affecting a high percentage of the country’s population.

Argentina has readily adopted technological change in dental procedures like the advent of new materials, mechanized instruments, and digitization both in the diagnosis. Dental costs in Argentina are considerably cheaper than in the U.S and most European countries.

No credit card required*

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Immunosuppressant Drugs Market Companies

NameProfile# EmployeesHQWebsite

Argentina Immunosuppressant Drugs Market

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Immunosuppressant Drugs Market will help companies and investors design strategic landscapes.


Monoclonal Antibodies was the largest segment with a revenue share of 72.6% in 2020.

Horizon Databook has segmented the Argentina immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.




Argentina is deemed to be one of the emerging markets worldwide but the country still struggles to maintain credibility with the investors and the inflation rates in the country have been very high.

Argentina’s health sector has gone through major transformations in the years with a reduction of state involvement in social services in favor of privatization and decentralization of healthcare. Dental caries and gingival affections are major oral health risks affecting a high percentage of the country’s population.

Argentina has readily adopted technological change in dental procedures like the advent of new materials, mechanized instruments, and digitization both in the diagnosis. Dental costs in Argentina are considerably cheaper than in the U.S and most European countries.

  • Argentina Immunosuppressant Drugs Market Drug Class Outlook (Revenue, USD Million , 2016-2027)
    • Calcineurin Inhibitors
    • mTOR Inhibitors
    • Antiproliferative Agents
    • Monoclonal Antibodies
    • Others
  • Argentina Immunosuppressant Drugs Market Application Outlook (Revenue, USD Million , 2016-2027)
    • Autoimmune Diseases
    • Organ Transplants
    • Other Applications
  • Argentina Immunosuppressant Drugs Market Route of Administration Outlook (Revenue, USD Million , 2016-2027)
    • Oral
    • Injectables
  • Argentina Immunosuppressant Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2016-2027)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Reasons to subscribe to Immunosuppressant Drugs Market databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Immunosuppressant Drugs Market databook

  • Our clientele includes a mix of Immunosuppressant Drugs Market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Argentina Immunosuppressant Drugs Market, including forecasts for subscribers. This country databook contains high-level insights into Argentina Immunosuppressant Drugs Market from 2016 to 2027, including revenue numbers, major trends, and company profiles.

Argentina Immunosuppressant Drugs Market, 2016-2027 (US$M)

No Access Stack Chart

Argentina immunosuppressant drugs market statistics, by drug class, 2016-2027 (US$M)

No Access Pie Chart

Argentina immunosuppressant drugs market statistics, by drug class, 2016-2027 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more